Journal article
PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia
HM McRae, AL Garnham, Y Hu, MT Witkowski, MA Corbett, MP Dixon, RE May, BN Sheikh, W Chiang, AJ Kueh, TA Nguyen, K Man, R Gloury, BJ Aubrey, A Policheni, LD Rago, WS Alexander, DHD Gray, A Strasser, ED Hawkins Show all
Blood | AMER SOC HEMATOLOGY | Published : 2019
Abstract
Somatically acquired mutations in PHF6 (plant homeodomain finger 6) frequently occur in hematopoietic malignancies and often coincide with ectopic expression of TLX3. However, there is no functional evidence to demonstrate whether these mutations contribute to tumorigenesis. Similarly, the role of PHF6 in hematopoiesis is unknown. We report here that Phf6 deletion in mice resulted in a reduced number of hematopoietic stem cells (HSCs), an increased number of hematopoietic progenitor cells, and an increased proportion of cycling stem and progenitor cells. Loss of PHF6 caused increased and sustained hematopoietic reconstitution in serial transplantation experiments. Interferon-stimulated gene ..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by an Australian Postgraduate Award (H.M.M.), National Health and Medical Research Council (NHMRC) Project grants 1029481 and 1084248, NHMRC Program grants (1016701 [A.S.] and 1113577 [W.S.A.]), NHMRC Research Fellowships (1003435 [T.T.], 575512 and 1081421 [A.K.V.], 1020363 [A.S.], and 1058344 [W.S.A.]), Independent Research Institutes Infrastructure Support Scheme from the Australian Government's NHMRC, and a Victorian State Government Operational Infrastructure Support Grant.